5F-MDMB-PICA

From Food & Medicine Encyclopedia

5F-MDMB-PICA

{{Drugbox | verifiedrevid = 477318464 | IUPAC_name = Methyl 2-[[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino]-3,3-dimethylbutanoate | image = 5F-MDMB-PICA_structure.png | width = 200 | legal_uk = Class B | legal_us = Schedule I | legal_ca = Schedule II | legal_de = Anlage II | CAS_number = 1971007-92-7 | PubChem = 119025022 | ChemSpiderID = 52085000 | UNII = 7J1X0F7F3V | C=20 | H=28 | F=1 | N=3 | O=3 | smiles = CC(C)(C)C(C(=O)OC)NC(=O)c1cn(CCCCC(F)F)c2c1cccc2 | StdInChI = 1S/C20H28FN3O3/c1-20(2,3)17(19(26)27-4)23-18(25)16-14-12-10-9-11-13(14)15(22-16)7-5-6-8-21/h9-12,17H,5-8H2,1-4H3,(H,22,23,25) | StdInChIKey = QWZQXKZQXQXQXQ-UHFFFAOYSA-N }}

5F-MDMB-PICA is a synthetic cannabinoid that has been used as an active ingredient in synthetic cannabis products. It is a potent agonist of the CB1 receptor and has been associated with numerous cases of severe toxicity and fatalities.

Chemical Structure and Properties[edit]

5F-MDMB-PICA is chemically classified as an indazole-based synthetic cannabinoid. Its IUPAC name is Methyl 2-[[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino]-3,3-dimethylbutanoate. The compound has a molecular formula of C20H28FN3O3 and a molecular weight of 377.46 g/mol.

Pharmacology[edit]

5F-MDMB-PICA acts as a potent agonist at the CB1 receptor, which is primarily responsible for the psychoactive effects of cannabinoids. The compound has a high binding affinity for the CB1 receptor, leading to strong psychoactive effects. It has been reported to cause severe adverse effects, including seizures, tachycardia, and acute kidney injury.

Legal Status[edit]

5F-MDMB-PICA is classified as a Schedule I controlled substance in the United States, indicating that it is considered to have a high potential for abuse and no accepted medical use. In the United Kingdom, it is classified as a Class B drug under the Misuse of Drugs Act 1971. It is also controlled under various international regulations.

Health Risks[edit]

The use of 5F-MDMB-PICA has been associated with numerous health risks. These include severe toxicity, psychosis, and death. The compound has been linked to multiple cases of overdose and has been found in various forensic toxicology reports.

Related Compounds[edit]

5F-MDMB-PICA is structurally related to other synthetic cannabinoids such as 5F-ADB, MDMB-CHMICA, and AB-FUBINACA. These compounds share similar pharmacological profiles and have been associated with similar adverse effects.

See Also[edit]

References[edit]

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.